{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:59:41Z","timestamp":1778237981679,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,6]]},"DOI":"10.7759\/cureus.59718","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:21:25Z","timestamp":1714990885000},"source":"Crossref","is-referenced-by-count":1,"title":["Unmanageable Cerebrospinal Fluid Leakage With Eosinophilic Meningitis in a Gliadel Wafer Implant Patient"],"prefix":"10.7759","author":[{"given":"Yuki","family":"Kawaguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunya","family":"Hanakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ikemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soichi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp R","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, et al.. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005, 352:987-96. 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal M","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, et al.. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003, 5:79-88. 10.1093\/neuonc\/5.2.79","journal-title":"Neuro Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1724-2","article-title":"Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis","volume":"122","author":"Chowdhary SA","year":"2015","unstructured":"Chowdhary SA, Ryken T, Newton HB. Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis. J Neurooncol. 2015, 122:367-82. 10.1007\/s11060-015-1724-2","journal-title":"J Neurooncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab189","article-title":"Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan","volume":"4","author":"Iuchi T","year":"2022","unstructured":"Iuchi T, Inoue A, Hirose Y, et al.. Long-term effectiveness of Gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Neurooncol Adv. 2022, 4:vdab189. 10.1093\/noajnl\/vdab189","journal-title":"Neurooncol Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(95)98902-q","article-title":"Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain","volume":"16","author":"Domb AJ","year":"1995","unstructured":"Domb AJ, Rock M, Perkin C, Yipchuck G, Broxup B, Villemure JG. Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain. Biomaterials. 1995, 16:1069-72. 10.1016\/0142-9612(95)98902-q","journal-title":"Biomaterials"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.oa.2021-0024","article-title":"Safety of Gliadel implant for malignant glioma: report of postmarketing surveillance in Japan","volume":"61","author":"Nishikawa R","year":"2021","unstructured":"Nishikawa R, Iwata H, Sakata Y, Muramoto K, Matsuoka T. Safety of Gliadel implant for malignant glioma: report of postmarketing surveillance in Japan. Neurol Med Chir (Tokyo). 2021, 61:536-48. 10.2176\/nmc.oa.2021-0024","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro A","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013, 310:1842-50. 10.1001\/jama.2013.280319","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.oa2013-0112","article-title":"A multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas","volume":"54","author":"Aoki T","year":"2014","unstructured":"Aoki T, Nishikawa R, Sugiyama K, et al.. A multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas. Neurol Med Chir (Tokyo). 2014, 54:290-301. 10.2176\/nmc.oa2013-0112","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3171\/2016.4.JNS152771","article-title":"Eosinophilic meningitis triggered by implanted Gliadel wafers: case report","volume":"126","author":"Saito K","year":"2017","unstructured":"Saito K, Yamasaki K, Yokogami K, Ivanova A, Takeishi G, Sato Y, Takeshima H. Eosinophilic meningitis triggered by implanted Gliadel wafers: case report. J Neurosurg. 2017, 126:1783-7. 10.3171\/2016.4.JNS152771","journal-title":"J Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241060-00002","article-title":"Pharmacokinetics of the carmustine implant","volume":"41","author":"Fleming AB","year":"2002","unstructured":"Fleming AB, Saltzman WM. Pharmacokinetics of the carmustine implant. Clin Pharmacokinet. 2002, 41:403-19. 10.2165\/00003088-200241060-00002","journal-title":"Clin Pharmacokinet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/250364-unmanageable-cerebrospinal-fluid-leakage-with-eosinophilic-meningitis-in-a-gliadel-wafer-implant-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:21:29Z","timestamp":1714990889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/250364-unmanageable-cerebrospinal-fluid-leakage-with-eosinophilic-meningitis-in-a-gliadel-wafer-implant-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,6]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.59718","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,6]]}}}